+Search query
-Structure paper
Title | Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer. |
---|---|
Journal, issue, pages | Nat Cancer, Vol. 3, Page 710-722, Year 2022 |
Publish date | Jun 24, 2021 (structure data deposition date) |
![]() | Shiba-Ishii, A. / Johnson, T.W. / Dagogo-Jack, I. / Mino-Kenudson, M. / Johnson, T.R. / Wei, P. / Weinrich, S.L. / McTigue, M.A. / Walcott, M.A. / Nguyen-Phuong, L. ...Shiba-Ishii, A. / Johnson, T.W. / Dagogo-Jack, I. / Mino-Kenudson, M. / Johnson, T.R. / Wei, P. / Weinrich, S.L. / McTigue, M.A. / Walcott, M.A. / Nguyen-Phuong, L. / Dionne, K. / Acker, A. / Kiedrowski, L.A. / Do, A. / Peterson, J.L. / Barth, J.L. / Yeap, B.Y. / Gainor, J.F. / Lin, J.J. / Yoda, S. / Hata, A.N. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 1.831 - 1.935 Å |
Structure data | ![]() PDB-7r7k: ![]() PDB-7r7r: |
Chemicals | ![]() ChemComp-25J: ![]() ChemComp-HOH: ![]() ChemComp-AWJ: |
Source |
|
![]() | TRANSFERASE / kinase |